Integra LifeSciences Holdings Corporation IART
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +2.66%
- 1 year
- +7.96%
- Open
- 12.74
- Prev close
- 12.83
- Mkt cap
- 991.60M
- Vol
- 1.04M
- Avg vol
- 948.94K
- EPS
- 0.17
- P/E
- 75.00
- Div yield
- 0.00%
More statistics
- Low
- 12.34
- High
- 12.85
- Forward P/E
- 5.29
- Beta
- 1.21
- Short ratio
- 8.11
- Inst. own
- 98.42%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 21, 2026
- 50-d avg
- 15.76
- 200-d avg
- 14.09
- 1y target
- 18.00
2Y chart
Events in this range
- Jul 31, 2025Earnings: 0.45; estimate 0.43; surprise 4.65%
- Oct 30, 2025Earnings: 0.54; estimate 0.43; surprise 25.58%
- Feb 26, 2026Earnings: 0.83; estimate 0.79; surprise 5.06%
- May 5, 2026Earnings: 0.54; estimate 0.41; surprise 31.71%
- Jul 16, 2026Rating: Truist Securities · Hold → Hold
- Jul 28, 2026Rating: UBS · — → Neutral
- Jul 29, 2026Earnings: 0.56; estimate 0.4805; surprise 16.55%
- Jul 30, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Oct 5, 2026Rating: BMO Capital · Market Perform → Market Perform
- Oct 5, 2026Rating: Citigroup · Neutral → Neutral
- Oct 14, 2026Rating: Truist Securities · Hold → Hold
- Oct 21, 2026Earnings: —; estimate 0.557; surprise —%
Signals (98)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 2026 | 2 days ago |
| MACD: Sell Signal | Oct 21, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 2, 2026 | 4 weeks ago |
| MACD: Sell Signal | Oct 2, 2026 | 4 weeks ago |
| RSI: Oversold | Oct 2, 2026 | 4 weeks ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 2 months ago |
| SMA: Bearish | Jul 29, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 16, 2026 | 3 months ago |
| RSI: Overbought | Jun 26, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 15, 2026 | 4 months ago |
| RSI: Overbought | Jun 9, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 4 months ago |
| RSI: Overbought | Jun 4, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| RSI: Overbought | May 26, 2026 | 5 months ago |
| RSI: Overbought | May 20, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 5 months ago |
| MACD: Buy Signal | May 5, 2026 | 5 months ago |
| RSI: Overbought | May 5, 2026 | 5 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | May 1, 2026 | 6 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 14, 2026 | 6 months ago |
| RSI: Overbought | Apr 14, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 24, 2026 | 7 months ago |
| RSI: Oversold | Mar 12, 2026 | 7 months ago |
| RSI: Oversold | Mar 9, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 11, 2026 | 8 months ago |
| SMA: Bearish | Jan 16, 2026 | 9 months ago |
| SMA: Bullish | Jan 15, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 14, 2026 | 9 months ago |
| SMA: Bearish | Jan 13, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 19, 2025 | 10 months ago |
| SMA: Bearish | Dec 16, 2025 | 10 months ago |
| SMA: Bullish | Dec 10, 2025 | 10 months ago |
| SMA: Bearish | Dec 5, 2025 | 11 months ago |
| SMA: Bullish | Dec 3, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 21, 2025 | 11 months ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 30, 2025 | 1 year ago |
| SMA: Bullish | Oct 16, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 16, 2025 | 1 year ago |
| SMA: Bearish | Oct 15, 2025 | 1 year ago |
| SMA: Bullish | Oct 14, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 10, 2025 | 1 year ago |
| SMA: Bearish | Oct 9, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 7, 2025 | 1 year ago |
| SMA: Bullish | Oct 3, 2025 | 1 year ago |
| SMA: Bearish | Oct 2, 2025 | 1 year ago |
| SMA: Bullish | Sep 30, 2025 | 1 year ago |
| SMA: Bearish | Sep 25, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 12, 2025 | 1 year ago |
| SMA: Bullish | Aug 7, 2025 | 1 year ago |
| SMA: Bearish | Aug 6, 2025 | 1 year ago |
| SMA: Bullish | Aug 5, 2025 | 1 year ago |
| SMA: Bearish | Aug 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 31, 2025 | 1 year ago |
| SMA: Bearish | Jul 30, 2025 | 1 year ago |
| SMA: Bullish | Jul 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| SMA: Bearish | Jul 11, 2025 | 1 year ago |
| SMA: Bullish | Jul 10, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jul 2, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 26, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 20, 2025 | 1 year ago |
| MACD: Buy Signal | May 15, 2025 | 1 year ago |
| MACD: Sell Signal | May 6, 2025 | 1 year ago |
| RSI: Oversold | May 5, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 25, 2025 | 1 year ago |
| RSI: Oversold | Apr 10, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 26, 2025 | 1 year ago |
| SMA: Bearish | Mar 12, 2025 | 1 year ago |
| SMA: Bullish | Mar 11, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 11, 2025 | 1 year ago |
| SMA: Bearish | Feb 26, 2025 | 1 year ago |
| SMA: Bullish | Feb 25, 2025 | 1 year ago |
| RSI: Oversold | Feb 21, 2025 | 1 year ago |
| SMA: Bearish | Feb 18, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 7, 2025 | 1 year ago |
| RSI: Overbought | Jan 24, 2025 | 1 year ago |
| SMA: Bullish | Jan 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 15, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 6, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
Key statistics
- Market cap
- 1.04B
- Enterprise value
- 2.82B
- Trailing P/E
- 0.00
- Forward P/E
- 5.29
- PEG ratio
- 0.67
- Price / sales
- 0.63
- Price / book
- 0.99
- EPS (TTM)
- -0.09
- Beta
- 1.21
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -0.44%
- Revenue (TTM)
- 1.65B
- Revenue growth
- 0.80%
- Free cash flow
- 94.40M
- Total cash
- 274.08M
- Total debt
- 2.05B
- Return on equity
- -0.70%
- Shares outstanding
- 77.77M
- Short % of float
- 12.88%
- 50-day average
- 15.76
- 200-day average
- 14.09
Analyst view
Consensus: hold
- Target (low)
- 14.00
- Target (mean)
- 18.00
- Target (high)
- 27.00
- Strong buy1
- Buy2
- Hold7
- Sell0
- Strong sell2
Next earnings
Oct 21, 2026
Expected Oct 21, 2026. Consensus EPS estimate 0.55915.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 21, 2026 | Sep 30, 2026 | 0.557 | — | — | — |
| Jul 29, 2026 | Jun 30, 2026 | 0.4805 | 0.56 | +0.08 | +16.55% |
| May 5, 2026 | Mar 31, 2026 | 0.41 | 0.54 | +0.13 | +31.71% |
| Feb 26, 2026 | Dec 31, 2025 | 0.79 | 0.83 | +0.04 | +5.06% |
| Oct 30, 2025 | Sep 30, 2025 | 0.43 | 0.54 | +0.11 | +25.58% |
| Jul 31, 2025 | Jun 30, 2025 | 0.43 | 0.45 | +0.02 | +4.65% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | Truist Securities | main | Hold | Hold |
| Oct 5, 2026 | Citigroup | main | Neutral | Neutral |
| Oct 5, 2026 | BMO Capital | main | Market Perform | Market Perform |
| Jul 30, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Jul 28, 2026 | UBS | init | — | Neutral |
| Jul 16, 2026 | Truist Securities | main | Hold | Hold |
About Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- integralife.com
News
- Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IART
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IART
- UBS Maintains Neutral on Integra Lifesciences, Lowers Price Target to $14
- Truist Securities Maintains Hold on Integra Lifesciences, Lowers Price Target to $13
- Citigroup Maintains Neutral on Integra Lifesciences, Lowers Price Target to $14
- BMO Capital Maintains Market Perform on Integra Lifesciences, Lowers Price Target to $14
- Wells Fargo Maintains Equal-Weight on Integra Lifesciences, Lowers Price Target to $13
- Citizens Maintains Market Outperform on Integra Lifesciences, Lowers Price Target to $22
- JP Morgan Maintains Underweight on Integra Lifesciences, Lowers Price Target to $14
Your note
Sign in to keep a note on IART — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BRADLEY KEITH | Director | Stock Award(Grant) | May 8, 2025 | 89,136 |
| CLAY SHAUNDRA | Director | Stock Award(Grant) | May 8, 2025 | 41,515 |
| DAVIS ROBERT T JR | Officer | Stock Award(Grant) | Mar 10, 2025 | 75,561 |
| ESSIG STUART PH.D. | Officer and Director | Stock Award(Grant) | May 8, 2025 | 1,785,270 |
| GRAVES JEFFREY A. | Director | Purchase | Nov 4, 2025 | 41,086 |
| HILL BARBARA BENTON | Director | Stock Award(Grant) | May 6, 2026 | 187,541 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 13.74% | 10,684,103 | 142.42M | Jun 29, 2026 |
| Rubric Capital Management LP | 9.97% | 7,753,934 | 103.36M | Jun 29, 2026 |
| Invesco Ltd. | 4.82% | 3,749,367 | 49.98M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.81% | 3,743,093 | 49.90M | Jun 29, 2026 |
| Morgan Stanley | 4.62% | 3,593,079 | 47.90M | Jun 29, 2026 |
| Fuller & Thaler Asset Management Inc. | 4.42% | 3,436,006 | 45.80M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.24% | 4,072,320 | 54.28M | Aug 30, 2026 |
| AIM Sector Funds (Invesco Sector Funds)-Invesco Small Cap Value Fund | 4.36% | 3,389,024 | 45.18M | Jul 30, 2026 |
| UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd. | 3.63% | 2,822,343 | 37.62M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.71% | 2,108,295 | 28.10M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.26% | 1,754,199 | 23.38M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.95% | 1,515,002 | 20.19M | Jun 29, 2026 |